Staidson Biopharma Inc. clinical trials
A subsidiary of Staidson (Beijing) Biopharmaceuticals Co., Ltd
The registry lists 1 studies whose lead sponsor is Staidson Biopharma Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Apr 18, 2022.
Registry sponsor names on this page
- Staidson Biopharma Inc.1 study
Something wrong with this grouping? Tell us on the Staidson (Beijing) Biopharmaceuticals Co., Ltd page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Staidson (Beijing) Biopharmaceuticals Co., Ltd studies →
- The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy SubjectsCompletedNCT05085197Phase 1
Sponsor listed in the registry: Staidson Biopharma Inc.